甲ML免疫悖论:解码逃生途径和开创检查点,疫苗和组合策略
Hamed Soleimani Samarkhazan1, Fatemeh Sadat Shafiei2, Zahra Taghinejad3
1Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hamed.soleiamni.s@gmail.com.
新的免疫疗法,包括免疫检查点抑制剂和疫苗,正在出现,以对抗急性髓性白血病 (AML). 这些策略针对免疫抑制瘤微环境,以提高患者的生存率.
科学领域:
- 血液学和瘤学研究
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 急性髓性白血病 (AML) 是一种高死亡率的癌症,其特点是免疫抑制性瘤微环境 (TME),阻碍免疫监测,导致尽管目前的治疗方法,但5年生存率为30%左右.
- 通过调节途径,AML积极抑制细胞毒性T和NK细胞,创造了一个"免疫悖论",需要新的治疗干预措施.
- 化学疗法和向疗法等现有治疗方法的疗效有限,这凸显了对创新免疫疗法的迫切需要.
研究的目的:
- 审查AML免疫治疗的机制,挑战和未来的方向.
- 突出免疫检查点抑制剂 (ICI) 和治疗疫苗在改善AML患者治疗结果方面的潜力.
- 探索克服免疫逃避和增强抗白血病反应的新兴策略.
主要方法:
- 对AML免疫疗法的当前文献的审查,重点关注免疫检查点抑制剂 (例如,抗PD-1,抗CD47) 和治疗性疫苗.
- 分析涉及低甲基化剂 (HMA),STING激动剂和双检查点封锁的组合方法.
- 讨论单细胞基因组学,人工智能和合成生物学在目标识别和患者分层方面的进展.
主要成果:
- 免疫检查点抑制剂 (ICI) 与低甲基化剂 (HMA) 结合,有望增强T细胞活性和细胞化,特别是在TP53突变的AML.
- 针对白血病相关抗原的治疗性疫苗已经在通过激活树突细胞来延长缓解方面取得了早期成功.
- 针对多种免疫抑制途径的组合策略有可能克服治疗耐药性.
结论:
- 免疫疗法,包括ICI和疫苗,是改善急性髓性白血病治疗结果的前沿.
- 解决诸如TME异质性,治疗耐药性,毒性和复发等挑战对于成功的临床转化至关重要.
- 整合基因组学和人工智能等先进技术可能使个性化治疗策略成为可能,并改变AML管理.
更多相关视频
08:06Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
Published on: November 26, 2010
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cell-mediated Immune Responses
